Adello Biologics is a Chicago-based pharmaceutical company focused exclusively on biosimilars—drugs that have been deemed to be highly similar in quality, safety and effectiveness to existing, branded biologics. By introducing competition into the biologic market, biosimilars can reduce costs, increase accessibility, and provide patients with more options.
"The team is collaborative, listens to concerns and executes great work product, again and again." - Celina Dopoulos | Sr. Director, Brand Strategy
